Comparison of bivalent and monovalent mRNA vaccine boosters
In this cohort study conducted in Hong Kong where both bivalent and monovalent
formulations of BNT162b2 were available, there were no significant differences in the …
formulations of BNT162b2 were available, there were no significant differences in the …
[HTML][HTML] Effectiveness of azvudine in reducing mortality of COVID-19 patients: a systematic review and meta-analysis
Y Wang, H Xie, L Wang, J Fan, Y Zhang, S Pan… - Virology Journal, 2024 - Springer
Background Azvudine has been approved for the treatment of coronavirus disease 2019
(COVID-19) patients in China, and this meta-analysis aims to illustrate the safety of azvudine …
(COVID-19) patients in China, and this meta-analysis aims to illustrate the safety of azvudine …
Effectiveness of mRNA BNT162b2 and inactivated CoronaVac vaccines against severe COVID-19 outcomes among non-hospitalised children aged 1-3 years with …
Objectives Clinical evidence on the effectiveness of COVID-19 vaccines for children aged 1–
3 years is scarce. The effectiveness of COVID-19 vaccines was evaluated among non …
3 years is scarce. The effectiveness of COVID-19 vaccines was evaluated among non …
[HTML][HTML] Molnupiravir for the treatment of COVID-19 outpatients: An updated meta-analysis
Background The majority of available data on molnupiravir come from an unvaccinated
COVID-19 population. Therefore, we conducted this meta-analysis to integrate evidence …
COVID-19 population. Therefore, we conducted this meta-analysis to integrate evidence …
[HTML][HTML] Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study
This study investigates the intricate interplay between Metabolic-associated Fatty Liver
Disease (MAFLD) and COVID-19, exploring the impact of MAFLD on disease severity …
Disease (MAFLD) and COVID-19, exploring the impact of MAFLD on disease severity …
COVID-19 hospitalization risk after outpatient nirmatrelvir/ritonavir use, January to August 2022, North Carolina
HI Henderson, DA Wohl, WA Fischer… - Journal of …, 2024 - academic.oup.com
Background In the USA, nirmatrelvir/ritonavir is authorized for the treatment of mild-to-
moderate COVID-19 in patients at least 12 years of age, at high risk for progression to …
moderate COVID-19 in patients at least 12 years of age, at high risk for progression to …
[PDF][PDF] Combating pan-coronavirus infection by indomethacin through simultaneously inhibiting viral replication and inflammatory response
Severe infections with coronaviruses are often accompanied with hyperinflammation,
requiring therapeutic strategies to simultaneously tackle the virus and inflammation. By …
requiring therapeutic strategies to simultaneously tackle the virus and inflammation. By …
Timing of BNT162b2 vaccine prior to COVID‐19 infection, influence disease severity in patients with hematologic malignancies: Results from a cohort study
O Gutwein, K Herzog Tzarfati, A Apel… - Cancer …, 2023 - Wiley Online Library
The COVID‐19 pandemic continues to pose challenges to the treatment of hemato‐
oncology patients. Emergence of COVID‐19 variants, availability of vaccine boosters and …
oncology patients. Emergence of COVID‐19 variants, availability of vaccine boosters and …
Combination of spironolactone and DPP-4 inhibitors for treatment of SARS-CoV-2 infection: a literature review
K Asadipooya, A Asadipooya, R Adatorwovor - Archives of Virology, 2024 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is still causing hospitalization and death,
and vaccination appears to become less effective with each emerging variant. Spike, non …
and vaccination appears to become less effective with each emerging variant. Spike, non …
AntiViralDL: Computational Antiviral Drug Repurposing Using Graph Neural Network and Self-Supervised Learning
Viral infections have emerged as significant public health concerns for decades. Antiviral
drugs, specifically designed to combat these infections, have the potential to reduce the …
drugs, specifically designed to combat these infections, have the potential to reduce the …